Workflow
Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates
DAREDaré Bioscience(DARE) ZACKS·2025-05-14 06:10

Dare Bioscience, Inc. (DARE) came out with a quarterly loss of 0.50pershareversustheZacksConsensusEstimateofalossof0.50 per share versus the Zacks Consensus Estimate of a loss of 0.63. This compares to loss of 0.84pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof20.630.84 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 20.63%. A quarter ago, it was expected that this company would post a loss of 0.66 per share when it actually produced a loss of $0.64, delivering a surprise of 3.03%.Over the last four quarters, the company has sur ...